PL2654723T3 - Stałe postacie leku zawierające tadalafil i sposoby ich otrzymywania - Google Patents
Stałe postacie leku zawierające tadalafil i sposoby ich otrzymywaniaInfo
- Publication number
- PL2654723T3 PL2654723T3 PL11813321T PL11813321T PL2654723T3 PL 2654723 T3 PL2654723 T3 PL 2654723T3 PL 11813321 T PL11813321 T PL 11813321T PL 11813321 T PL11813321 T PL 11813321T PL 2654723 T3 PL2654723 T3 PL 2654723T3
- Authority
- PL
- Poland
- Prior art keywords
- tadalafil
- preparation
- methods
- dosage forms
- pharmaceutical dosage
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1682—Processes
- A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/4985—Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
Landscapes
- Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP2010460052 | 2010-12-23 | ||
PCT/EP2011/006544 WO2012095151A1 (en) | 2010-12-23 | 2011-12-23 | Solid pharmaceutical dosage forms comprising tadalafil and methods of preparation thereof |
EP11813321.4A EP2654723B1 (en) | 2010-12-23 | 2011-12-23 | Solid pharmaceutical dosage forms comprising tadalafil and methods of preparation thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
PL2654723T3 true PL2654723T3 (pl) | 2015-05-29 |
Family
ID=45653340
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL11813321T PL2654723T3 (pl) | 2010-12-23 | 2011-12-23 | Stałe postacie leku zawierające tadalafil i sposoby ich otrzymywania |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP2654723B1 (pl) |
HR (1) | HRP20150158T1 (pl) |
PL (1) | PL2654723T3 (pl) |
SI (1) | SI2654723T1 (pl) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2014167579A2 (en) * | 2013-03-28 | 2014-10-16 | Astron Research Limited | Stable pharmaceutical compositions of tadalafil |
CN113577079B (zh) * | 2021-07-28 | 2022-08-23 | 山东裕欣药业有限公司 | 一种磷酸二酯酶抑制剂的制备方法及组合物 |
CN113855639B (zh) * | 2021-11-04 | 2023-03-24 | 昆明源瑞制药有限公司 | 一种他达拉非片剂及其制备方法 |
-
2011
- 2011-12-23 PL PL11813321T patent/PL2654723T3/pl unknown
- 2011-12-23 EP EP11813321.4A patent/EP2654723B1/en not_active Not-in-force
- 2011-12-23 SI SI201130398T patent/SI2654723T1/sl unknown
-
2015
- 2015-02-09 HR HRP20150158TT patent/HRP20150158T1/hr unknown
Also Published As
Publication number | Publication date |
---|---|
SI2654723T1 (sl) | 2015-04-30 |
EP2654723A1 (en) | 2013-10-30 |
EP2654723B1 (en) | 2014-12-31 |
HRP20150158T1 (hr) | 2015-04-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1255336A1 (zh) | 藥物製劑及其製備方法 | |
IL272501A (en) | Oral administration forms of bendamustine and their medical use | |
EP2747563A4 (en) | COMPOSITIONS AND METHODS FOR ORAL ADMINISTRATION OF MEDICINAL PRODUCTS | |
EP2612655A4 (en) | LIQUID COMPOSITIONS OF INSOLUBLE DRUGS AND METHODS OF PREPARING THE SAME | |
ZA201206223B (en) | Certain kynurenine-3-monooxygenase inhibitors,pharmaceutical compositions, and methods of use thereof | |
HK1175947A1 (en) | Pharmaceutical compositions and methods of making same | |
IL220037A0 (en) | Compressible-coated pharmaceutical composiitons and tablets and methods of manufacture | |
GB201104473D0 (en) | Improved pharmaceutical compositions and methods of delivery | |
EP2563346A4 (en) | SOLID ORAL PHARMACEUTICAL FORMS WITH TADALAFIL | |
IL217239A0 (en) | Salts of rasagiline and pharmaceutical preparations thereof | |
GB201302653D0 (en) | Pharmaceutical compositions and methods of treatment | |
AP3441A (en) | Pharmaceutical compositions comprising hydromorphone and naloxone | |
EP2655410A4 (en) | ANTI-INFLAMMATORY PROTEINS AND METHODS OF PREPARATION AND USE THEREOF | |
EP2718283A4 (en) | INDAZOLE AND PYRROLOPYRIDINE DERIVATIVE AND PHARMACEUTICAL USE THEREOF | |
HK1183228A1 (zh) | 口服藥物治療方法和組合物 | |
IL225606A0 (en) | A method for preparing an inactive supplement suitable for pharmaceutical use | |
EP2734513A4 (en) | INTERMEDIATE PRODUCT OF STATIN MEDICINES AND THEIR MANUFACTURE | |
SI2536396T1 (sl) | Postopek za pripravo oralnih trdnih odmernih oblik, ki obsegajo valsartan | |
EP2701689A4 (en) | PHARMACEUTICAL COMPOSITIONS OF RALTEEGRAVIR, METHODS OF PREPARATION AND USE THEREOF | |
PL2654723T3 (pl) | Stałe postacie leku zawierające tadalafil i sposoby ich otrzymywania | |
LT2698150T (lt) | Per burną vartojamas kietas prieštuberkuliozinio junginio vaistinis preparatas ir jo paruošimo būdas | |
IL222714A0 (en) | Preparation of polypeptides and salts thereof | |
EP2649999A4 (en) | USE OF QUINAZOLIN COMPOUND IN THE PREPARATION OF ANTI-FLAVIVIRUS MEDICINE | |
EP2536688A4 (en) | STABLE DOSAGE FORMS OF LEVOMILNACIPRAN | |
EP2668961A4 (en) | PHARMACEUTICAL COMBINATION PREPARATION |